| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8227436 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 7 Pages | 
Abstract
												The combination of salvage radiosurgery and bevacizumab to treat recurrent malignant gliomas is well tolerated and seems to be associated with improved outcomes. Prospective multiinstitutional studies are required to determine efficacy and long-term toxicity with this approach.
											Related Topics
												
													Physical Sciences and Engineering
													Physics and Astronomy
													Radiation
												
											Authors
												Kyle C. M.D., James J. M.D., John H. M.D., Ph.D., David A. M.D., Annick M.D., Katherine B. M.D., Ph.D., Henry S. M.D., Christopher G. M.D., John P. M.D., Ph.D., 
											